Status:
RECRUITING
The Safety and Efficacy of Fecal Microbiota Transplantation in the Treatment of Digestive Diseases and Non-digestive System Diseases Associated With Gastrointestinal Symptoms in the Gastrointestinal Tract.
Lead Sponsor:
Shanghai 10th People's Hospital
Conditions:
Fecal Microbiota Transplantation
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The exploration of the safety and efficacy of fecal microbiota transplantation in the treatment of non-digestive system diseases associated with gastrointestinal symptoms in the gastrointestinal tract...
Eligibility Criteria
Inclusion
- Being able to tolerate a nasoenteric tube or swallow a capsule.
Exclusion
- Intestinal barrier dysfunction. Inability to tolerate enteral nutrition.
Key Trial Info
Start Date :
January 10 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 10 2025
Estimated Enrollment :
10000 Patients enrolled
Trial Details
Trial ID
NCT06208930
Start Date
January 10 2018
End Date
December 10 2025
Last Update
January 24 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Le Wang
Shanghai, Shanghai Municipality, China, 200040